Tag Archives: Fibrosis

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime – BioSpace

  ORLANDO, Fla., Jan. 6, 2020 /PRNewswire/ — AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., is pleased to include Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), a new breakthrough therapy for cystic fibrosis (CF), among other specialty medications available through its pharmacy. Cystic fibrosis is a rare, progressive, life-threatening disease… Read More »

Modifier Gene May Explain Why Some with Cystic Fibrosis are Less Prone to Infection

Cystic fibrosis is caused by an inherited mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Due to this mutation, the CFTR protein doesn’t embed in cell membranes to form a channel for chlorine ions the way it should. As a result, mucus-producing cells secrete a thicker-than-normal mucus that can create blockages in the lungs and… Read More »

Prophylactic Azithromycin Beneficial in Idiopathic Pulmonary Fibrosis

December 14, 2018 Share this content: The number of hospital admissions and antibiotics prescribed dropped in participants who took prophylactic azithromycin. Prophylactic azithromycin may reduce hospital stays and the need for rescue antibiotics in patients with idiopathic pulmonary fibrosis (IPF), according to a retrospective study published in the European Respiratory Journal. Researchers analyzed the use of… Read More »